Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, mucinous adenocarcinoma, neoplasm, pancreas disorder, pancreatic adenosquamous carcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasm	Not yet recruiting	Phase 1 / Phase 2	2026-06-24		NCT07665684

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Health Network, Toronto	417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Princess Margaret Cancer Centre	Toronto	Canada	9